XML 43 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited) (USD $)
 6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
OPERATING ACTIVITIES:    
Net Loss attributable to the Company $ (140,727) $ (519,053)
Add: Net loss attributable to non-controlliong interest 0 191
Net loss (140,727) (518,862)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 18,344 49,883
Amortization of debt discount 16,606   
Finance charges in connection with convertible debt 23,995   
Common Stock and options issued for services 37,915 208,827
Amortization of deferred compensation    36,562
Changes in operating assets and liabilities:    
(Increase) in Accounts Receivable (176,545)   
(Increase) in Inventory    (1,024)
(Increase) Decrease in prepaid expenses and other current assets 2,598 2,862
Decrease in miscellaneous receivable 7,370   
Increase in Accounts Payable and Accrued Liabilities 5,261 78,082
(Decrease) in customer deposits    (53,940)
Net cash (used in) operating activities (205,183) (197,610)
INVESTING ACTIVITIES:    
Purchase of equipment (45,972) (1,969)
Net cash used in investing activities (45,972) (1,969)
FINANCING ACTIVITIES:    
Cash Overdraft (1,309)   
Proceeds from the sale of common stock 130,000 127,500
Proceeds from Loan Payable - Related Party 47,662 33,241
Proceeds from Convertible Notes Payable 100,000   
Payments of Loan Payables    (1,412)
Payments of Notes Payable (2,157) (3,931)
Net Cash Provided by Financing Activities 274,196 155,398
Effect of exchange rate change    648
Increase (decrease) in cash and cash equivalents 23,041 (43,533)
Cash and cash equivalents at beginning of period    61,179
Cash and cash equivalents at end of period 23,041 17,646
Cash paid during the period for:    
Interest expense 7,370 6,401
Income taxes      
Supplemental Disclosures of Cash Flow Information (Non Cash Financing Activities):    
Common stock issued as consideration for accrued expenses 3,000 14,875
Accrued expenses applied for option exercise    1,000
Payment of accrued expenses by former director applied to additional paid in capital $ 27,000